- Home
- PLRX vs AMBC Comparison
PLRX vs AMBC Comparison
Compare PLRX & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- AMBC
- Stock Information
- Founded
- PLRX 2015
- AMBC 1971
- Country
- PLRX United States
- AMBC United States
- Employees
- PLRX N/A
- AMBC N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- PLRX Health Care
- AMBC Finance
- Exchange
- PLRX Nasdaq
- AMBC Nasdaq
- Market Cap
- PLRX 77.3M
- AMBC 411.3M
- IPO Year
- PLRX 2020
- AMBC 1991
- Fundamental
- Price
- PLRX $1.45
- AMBC $7.09
- Analyst Decision
- PLRX Hold
- AMBC Strong Buy
- Analyst Count
- PLRX 10
- AMBC 1
- Target Price
- PLRX $9.79
- AMBC $15.00
- AVG Volume (30 Days)
- PLRX 1.6M
- AMBC 935.0K
- Earning Date
- PLRX 08-06-2025
- AMBC 08-04-2025
- Dividend Yield
- PLRX N/A
- AMBC N/A
- EPS Growth
- PLRX N/A
- AMBC N/A
- EPS
- PLRX N/A
- AMBC N/A
- Revenue
- PLRX N/A
- AMBC $253,912,000.00
- Revenue This Year
- PLRX N/A
- AMBC N/A
- Revenue Next Year
- PLRX N/A
- AMBC $17.41
- P/E Ratio
- PLRX N/A
- AMBC N/A
- Revenue Growth
- PLRX N/A
- AMBC 125.08
- 52 Week Low
- PLRX $1.10
- AMBC $5.99
- 52 Week High
- PLRX $16.10
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- PLRX 57.77
- AMBC 46.27
- Support Level
- PLRX $1.13
- AMBC $6.87
- Resistance Level
- PLRX $1.27
- AMBC $8.07
- Average True Range (ATR)
- PLRX 0.11
- AMBC 0.30
- MACD
- PLRX 0.03
- AMBC 0.03
- Stochastic Oscillator
- PLRX 87.67
- AMBC 19.67
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.